Leukapheresis study in people living with HIV
Part of Infections clinical trials.
This trial uses a special blood-filtering procedure (leukapheresis) along with blood tests to better understand how HIV affects the body. It may help researchers learn more about HIV “pathogenesis,” which means what drives disease in different people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV (HIV-positive).
- You can clearly agree to take part (able to give informed consent).
- You are willing to have blood drawn and/or undergo leukapheresis.
- You must fit one HIV group: controlled on meds with very low viral load, an “elite controller” with very low viral load without meds, or not on meds with a high viral load.
- You must not have anemia or major blood-clotting problems that make blood donation unsafe, and your platelet and clot-test numbers must be high enough.
- You must not have certain major health issues (like liver scarring/cirrhosis, very low albumin, certain high liver-enzyme levels, weight under 120 lb, unsafe blood pressure, or pregnancy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood to help researchers run multiple projects, including comparing people who are HIV-negative with people who have HIV. It may help advance knowledge that could improve future testing or treatments.
This study uses a small tissue sample from an often-accessible lymph node to learn how HIV affects the body. It may help researchers understand why some people control HIV better than others.
This research study collects blood cells from adults with HIV and their family members to understand why some people's immune systems control HIV better than others. Researchers will use your cells to study HIV immunity and develop better treatments.
This trial uses a special blood-removal procedure called apheresis to collect either plasma or white blood cells for laboratory research. It may help scientists understand infection or immune-related processes by providing specific blood components for study.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
This study measures how much HIV is in your blood and lymph node tissue. If you qualify, you would also allow blood and other tests (including genetic and hepatitis screening), which may help researchers better understand how HIV affects the body.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.